Citation Impact
Citing Papers
Salt-Sensitive Blood Pressure in Mice With Increased Expression of Aldosterone Synthase
2007 StandoutNobel
Melatonin attenuates D‐galactose‐induced memory impairment, neuroinflammation and neurodegeneration via RAGE /NF ‐KB /JNK signaling pathway in aging mouse model
2014 Standout
Neuroprotective Effect of Scutellarin on Ischemic Cerebral Injury by Down-Regulating the Expression of Angiotensin-Converting Enzyme and AT1 Receptor
2016
The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis
2018 Standout
A Systematic Comparison of the Properties of Clinically Used Angiotensin II Type 1 Receptor Antagonists
2013
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 Standout
A Review on Central Nervous System Effects of Gastrodin
2018 Standout
Vascular dementia
2015 Standout
Low-Density Lipoprotein Receptor-Related Protein-1 Mediates Endocytic Clearance of Tissue Inhibitor of Metalloproteinases-1 and Promotes Its Cytokine-Like Activities
2014 StandoutNobel
Ageing as a risk factor for neurodegenerative disease
2019 Standout
Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations
2011 Standout
Oxidative Stress at the Vascular Wall. Mechanistic and Pharmacological Aspects
2006
NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches
2018 Standout
Impact and Therapeutic Potential of PPARs in Alzheimers Disease
2011
Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer’s disease
2017
The peroxisome proliferators activated receptor-gamma agonists as therapeutics for the treatment of Alzheimer's disease and mild-to-moderate Alzheimer's disease: a meta-analysis
2015
An adult tissue-specific stem cell in its niche: A gene profiling analysis of in vivo quiescent and activated muscle satellite cells
2009
The role of antioxidants in the chemistry of oxidative stress: A review
2015 Standout
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
AT2 receptors: Functional relevance in cardiovascular disease
2008
Pre-clinical models of human cerebral small vessel disease: Utility for clinical application
2012
Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer
2006 Standout
Cerebral Arterial Pulsation Drives Paravascular CSF–Interstitial Fluid Exchange in the Murine Brain
2013 Standout
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Experimental models of vascular dementia and vascular cognitive impairment: a systematic review
2010
The Pathobiology of Vascular Dementia
2013 Standout
Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective
2020 Standout
Aldosterone and end-organ damage
2005
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
Chronic blockade of the AT2 receptor with PD123319 impairs insulin signaling in C57BL/6 mice
2016
Hydroethidine- and MitoSOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: Another inconvenient truth
2010
Metzincin Proteases and Their Inhibitors: Foes or Friends in Nervous System Physiology?
2010
Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis
2019
Cellular senescence: from physiology to pathology
2014 Standout
Melatonin and the theories of aging: a critical appraisal of melatonin's role in antiaging mechanisms
2013
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Gastrodin improves cognitive dysfunction and decreases oxidative stress in vascular dementia rats induced by chronic ischemia.
2015
Nonhypotensive Dose of Telmisartan Attenuates Cognitive Impairment Partially Due to Peroxisome Proliferator-Activated Receptor-γ Activation in Mice With Chronic Cerebral Hypoperfusion
2010
Diabetic Cardiomyopathy
2018 Standout
Aldosterone and Vascular Inflammation
2008
Hypertension Induces Somatic Cellular Senescence in Rats and Humans by Induction of Cell Cycle Inhibitor p16 INK4a
2008
Novel Therapeutic Role for Dipeptidyl Peptidase III in the Treatment of Hypertension
2016
Oxidative Stress and Metabolic Syndrome: Cause or Consequence of Alzheimer's Disease?
2014
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2020 Standout
Smart Logistics Path for Cyber-Physical Systems With Internet of Things
2018 Standout
Pathophysiology of Sleep Apnea
2010 Standout
Diabetes Mellitus and Blood-Brain Barrier Dysfunction: An Overview
2014
Superoxide Ion: Generation and Chemical Implications
2016 Standout
Neurovascular Coupling in Cognitive Impairment Associated With Diabetes Mellitus
2011
ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension
2015
Current Approaches Against Alzheimer's Disease in Clinical Trials
2016 Standout
Bioactive Compounds and Biological Functions of Garlic (Allium sativum L.)
2019 Standout
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
Effects and Mechanisms of Fruit and Vegetable Juices on Cardiovascular Diseases
2017
Aldosterone and end-organ damage
2007
Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
2012 Standout
Renin‐Angiotensin System: An Old Player with Novel Functions in Skeletal Muscle
2015
Vascular Aspects of Cognitive Impairment and Dementia
2013
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China
2020 Standout
Works of Jun Iwanami being referenced
Female type 2 diabetes mellitus mice exhibit severe ischemic brain damage
2011
Timp-3 deficiency impairs cognitive function in mice
2009
Drinking Citrus Fruit Juice Inhibits Vascular Remodeling in Cuff-Induced Vascular Injury Mouse Model
2015
Telmisartan prevented cognitive decline partly due to PPAR-γ activation
2008
Administration of bovine casein-derived peptide prevents cognitive decline in Alzheimer disease model mice
2017
Pretreatment with eplerenone reduces stroke volume in mouse middle cerebral artery occlusion model
2007
Inhibition of cognitive decline in mice fed a high-salt and cholesterol diet by the angiotensin receptor blocker, olmesartan
2007
Direct Angiotensin II Type 2 Receptor Stimulation Ameliorates Insulin Resistance in Type 2 Diabetes Mice with PPARγ Activation
2012
ACE2 deficiency induced perivascular fibrosis and cardiac hypertrophy during postnatal development in mice
2013
Attenuation of Focal Brain Ischemia by Telmisartan, an Angiotensin II Type 1 Receptor Blocker, in Atherosclerotic Apolipoprotein E-Deficient Mice
2008
Low dose of telmisartan prevents ischemic brain damage with peroxisome proliferator-activated receptor-γ activation in diabetic mice
2010
Irbesartan attenuates ischemic brain damage by inhibition of MCP-1/CCR2 signaling pathway beyond AT1 receptor blockade
2011
Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence
2007
Inhibition of the renin–angiotensin system and target organ protection
2009
Effect of Azelnidipine on Angiotensin II-Mediated Growth-Promoting Signaling in Vascular Smooth Muscle Cells
2005
The calcium-channel blocker, azelnidipine, enhances the inhibitory action of AT1 receptor blockade on ischemic brain damage
2006
Amlodipine Treatment Reduces Stroke Size in Apolipoprotein E–Deficient Mice
2006
Roles of Interleukin 17 in Angiotensin II Type 1 Receptor–Mediated Insulin Resistance
2011
Roles of Brain Angiotensin II in Cognitive Function and Dementia
2012
Angiotensin II Type 2 Receptor Deletion Enhances Vascular Senescence by Methyl Methanesulfonate Sensitive 2 Inhibition
2008
Direct Stimulation of Angiotensin II Type 2 Receptor Enhances Spatial Memory
2011
Aldosterone and Angiotensin II Synergistically Induce Mitogenic Response in Vascular Smooth Muscle Cells
2005
Cognitive Deficit in Amyloid-β–Injected Mice Was Improved by Pretreatment With a Low Dose of Telmisartan Partly Because of Peroxisome Proliferator-Activated Receptor-γ Activation
2009
Peroxisome Proliferator-Activated Receptor-γ Activation With Angiotensin II Type 1 Receptor Blockade Is Pivotal for the Prevention of Blood-Brain Barrier Impairment and Cognitive Decline in Type 2 Diabetic Mice
2012
Angiotensin II Type-2 Receptor Stimulation Prevents Neural Damage by Transcriptional Activation of Methyl Methanesulfonate Sensitive 2
2006
Amelioration of Cognitive Impairment in the Type-2 Diabetic Mouse by the Angiotensin II Type-1 Receptor Blocker Candesartan
2007